Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.
Krane, Vera
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN May 2010 - 874-81 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1555-905X
10.2215/CJN.01170209 doi
Aged
Antibodies--blood
Aspirin--adverse effects
Atorvastatin
Cause of Death
Chi-Square Distribution
Death, Sudden--etiology
Diabetes Mellitus, Type 2--complications
Double-Blind Method
Female
Germany
Heparin--immunology
Heptanoic Acids--therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Kaplan-Meier Estimate
Kidney Diseases--complications
Logistic Models
Male
Middle Aged
Myocardial Infarction--immunology
Platelet Aggregation Inhibitors--adverse effects
Platelet Factor 4--immunology
Proportional Hazards Models
Prospective Studies
Pyrroles--therapeutic use
Renal Dialysis--adverse effects
Risk Assessment
Risk Factors
Stroke--immunology
Time Factors
Treatment Outcome
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN May 2010 - 874-81 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1555-905X
10.2215/CJN.01170209 doi
Aged
Antibodies--blood
Aspirin--adverse effects
Atorvastatin
Cause of Death
Chi-Square Distribution
Death, Sudden--etiology
Diabetes Mellitus, Type 2--complications
Double-Blind Method
Female
Germany
Heparin--immunology
Heptanoic Acids--therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Kaplan-Meier Estimate
Kidney Diseases--complications
Logistic Models
Male
Middle Aged
Myocardial Infarction--immunology
Platelet Aggregation Inhibitors--adverse effects
Platelet Factor 4--immunology
Proportional Hazards Models
Prospective Studies
Pyrroles--therapeutic use
Renal Dialysis--adverse effects
Risk Assessment
Risk Factors
Stroke--immunology
Time Factors
Treatment Outcome